Spondyloepimetaphyseal dysplasia with elevated plasma lysosomal enzymes caused by homozygous variant in MBTPS1.

TitleSpondyloepimetaphyseal dysplasia with elevated plasma lysosomal enzymes caused by homozygous variant in MBTPS1.
Publication TypeJournal Article
Year of Publication2020
AuthorsCarvalho, DR, Speck-Martins, CE, Brum, JM, Ferreira, CR, Sobreira, NLM
JournalAm J Med Genet A
Volume182
Issue7
Pagination1796-1800
Date Published2020 07
ISSN1552-4833
KeywordsCataract, Child, Preschool, Female, Humans, Lysosomal Storage Diseases, Lysosomes, Pedigree, Phenotype, Proprotein Convertases, Serine Endopeptidases
Abstract

Variants in MBTPS1 (membrane-bound transcription factor peptidase, site 1) encoding the protein convertase site-1 protease (S1P) were recently reported in a single individual with skeletal dysplasia and elevated plasma lysosomal enzymes. Here, we report the second individual with this newly described autosomal recessive spondyloepiphyseal dysplasia (OMIM #618392), presenting severe growth retardation, cataract and dysmorphic features, mainly retromicrognathia. Epilepsy and craniosynostosis were novel findings in our proband. She was found to be homozygous for a novel nonsense variant p.Trp983Ter in MBTPS1. In addition, she had normal levels of lysosomal enzyme activity in leukocytes but elevated levels in plasma. Our description confirms the existence of this new skeletal dysplasia and expands the phenotype and genotype of the disease.

DOI10.1002/ajmg.a.61614
Alternate JournalAm J Med Genet A
PubMed ID32420688
PubMed Central IDPMC8136467
Grant ListP50 HD103538 / HD / NICHD NIH HHS / United States
UM1 HG006542 / HG / NHGRI NIH HHS / United States